Top Clinical Trials companies in Taiwan by Total Assets

This ranking features the top 3 Clinical Trials companies in Taiwan ranked by Total Assets, totalling a Total Assets of USD 789.36 M, for January 15, 2025.

Taiwan

Clinical Trials
Total Assets
#
Name
Total Assets
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
4128.TWO

Microbio Co., Ltd.

1

4128.TWO
USD 479.98 M
Dec. 31, 2023 USD 0.93 4.52%

Taiwan
2
4174.TWO

OBI Pharma, Inc.

2

4174.TWO
USD 182.54 M
Dec. 31, 2023 USD 1.70 1.57%

Taiwan
3
4147.TWO

TaiMed Biologics Inc.

3

4147.TWO
USD 126.84 M
Dec. 31, 2023 USD 2.64 -2.78%

Taiwan
Frequently Asked Questions
  • Which Clinical Trials company in Taiwan has the highest Total Assets ?

    The Clinical Trials company in Taiwan with the highest Total Assets is Microbio Co., Ltd. (Taipei Exchange: 4128.TWO) at USD 479.98 M.

  • Which Clinical Trials company in Taiwan has the lowest Total Assets ?

    The Clinical Trials company in Taiwan with the lowest Total Assets is TaiMed Biologics Inc. (Taipei Exchange: 4147.TWO) at USD 126.84 M.